Shares of Marchex, Inc. (NASDAQ:MCHX - Get Free Report) crossed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $1.84 and traded as high as $1.99. Marchex shares last traded at $1.93, with a volume of 5,514 shares traded.
Wall Street Analyst Weigh In
Separately, StockNews.com assumed coverage on Marchex in a report on Wednesday. They issued a "hold" rating on the stock.
Read Our Latest Research Report on MCHX
Marchex Price Performance
The firm has a market cap of $85.61 million, a price-to-earnings ratio of -21.78 and a beta of 1.91. The business has a 50-day moving average of $1.93 and a 200-day moving average of $1.84.
Marchex (NASDAQ:MCHX - Get Free Report) last announced its quarterly earnings data on Thursday, October 31st. The technology company reported ($0.02) earnings per share (EPS) for the quarter. Marchex had a negative return on equity of 10.76% and a negative net margin of 8.60%. The company had revenue of $12.55 million for the quarter, compared to the consensus estimate of $12.60 million. During the same quarter in the prior year, the company earned ($0.03) EPS. As a group, equities analysts anticipate that Marchex, Inc. will post -0.1 EPS for the current fiscal year.
Institutional Inflows and Outflows
A hedge fund recently raised its stake in Marchex stock. Geode Capital Management LLC raised its stake in Marchex, Inc. (NASDAQ:MCHX - Free Report) by 9.1% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 347,386 shares of the technology company's stock after purchasing an additional 29,042 shares during the period. Geode Capital Management LLC owned 0.80% of Marchex worth $650,000 at the end of the most recent quarter. Institutional investors own 73.46% of the company's stock.
About Marchex
(
Get Free Report)
Marchex, Inc, a conversation intelligence company, provides conversational analytics and related solutions in the United States, Canada, and internationally. Its products include Marketing Edge that identifies which campaigns and channels are driving inbound conversations, evaluates what happens during those conversations, and closes the sales loop by connecting converted sales to marketing driven leads; Sonar Business Text Messaging, an artificial intelligence (AI) empowered intelligent workflow enabled mobile messaging solution that enables operations, sales, and marketing teams to communicate personally with field staff, prospects, and customers; Marchex Platform Services, a robust API-based conversation intelligence product that allows executives, sales, customer engagement, and marketing teams to apply Marchex AI to most any calls, regardless of communication platform, in order to identify actionable insights from conversations with their customers; Spotlight, an AI conversation analytics product for multi-location businesses; and Engage, a solution that provides locations with applications to enhance their overall performance.
See Also
Before you consider Marchex, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Marchex wasn't on the list.
While Marchex currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.